BB BIOTECH N/ CH0038389992 /
2024-04-25 5:31:57 PM | Chg. -0.900 | Volume | Bid6:40:00 PM | Ask6:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.550CHF | -2.17% | 59,657 Turnover: 2.42 mill. |
40.150Bid Size: 1,200 | -Ask Size: 200 | 2.25 bill.CHF | 4.93% | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -3.77 CHF | -42.00% |
EPS Diluted: | - CHF | -42.00% |
Revenues per Share: | 0.01 CHF | -57.94% |
Book Value per Share: | 41.94 CHF | -13.51% |
Cash Flow per Share: | 3.94 CHF | -5.56% |
Dividend per Share: | 2.00 CHF | -29.82% |
Total | in mill. | |
Revenues: | 0.53 CHF | -57.94% |
Net Income: | -206.61 CHF | -42.26% |
Operating Cash Flow: | 218.28 CHF | - |
Cash and Cash Equivalents: | 0.50 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 4,238.62 | 4,468.58 |
P/BV ratio: | 0.97 | 1.02 |
P/CF Ratio: | 10.29 | 10.85 |
PEG: | 0.26 | - |
Earnings Yield: | -9.30% | -8.82% |
Dividend Yield: | 4.93% | 4.68% |
Market Capitalization | ||
Market Capitalization: | 2.25 bill. CHF | 2.37 bill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 23.9 mill. CHF | 25.2 mill. CHF |
Shares Outstanding: | 55.4 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | 0.00% |
Net Profit Margin: | -38,982.45% |
Return on Equity: | -8.89% |
Return on Assets: | -7.83% |
Financial Strength
Liquidity I / Cash Ratio: | - |
Liquidity II / Quick Ratio: | - |
Liquidity III / Current Ratio: | - |
Debt / Equity Ratio: | 13.51% |
Dynam. Debt / Equity Ratio: | 143.83% |
Efficiency
Employees: | 94 |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | 5,638.30 CHF |
Net Income / Employee: | -2,197,946.81 CHF |
Total Assets / Employee: | 28,054,829.79 CHF |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | CHF |